Bioactive ECM Gel Manufacturing via Alkaline Solubilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for manufacturing bioactive gels from extracellular matrix material are time-consuming and require aggressive purification steps, leading to bioactivity depletion and increased regulatory barriers.
Innovation Solution
The method involves solubilizing ECM in a basic environment, followed by neutralization, to create bioactive gels that retain bioactivity, avoiding cumbersome purification and reducing regulatory burdens, using alkaline compounds like NaOH and controlling solubilization and neutralization conditions to maintain bioactive molecule content.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If aggressive purification steps are used to manufacture bioactive gels from ECM, then purity of the gel is improved, but bioactivity is depleted and manufacturing time increases
Solution Approach 1:
The patent changes the chemical parameters of the manufacturing process by using mild solubilization conditions (pH 2.0-3.0, specific salt concentrations) instead of aggressive purification steps. This parameter change allows the gel to maintain bioactivity while achieving sufficient purity for tissue repair applications.
Solution Approach 2:
The patent employs a simplified, single-use manufacturing approach where the ECM is directly solubilized and formed into gels without complex multi-step purification. This disposable-style process reduces manufacturing complexity and time while preserving bioactive components.
2Manufacturing precision
If aggressive purification steps are used to manufacture bioactive gels from ECM, then purity of the gel is improved, but manufacturing time increases
Solution Approach 1:
The patent modifies the process parameters by using controlled solubilization at specific pH and temperature conditions, replacing time-consuming aggressive purification steps. This achieves adequate purity in a fraction of the time, significantly improving manufacturing productivity.
Solution Approach 2:
The patent skips the traditional multi-step aggressive purification sequence and rushes through the manufacturing process using direct solubilization and gel formation. This streamlined approach maintains essential purity while dramatically reducing manufacturing time.
3Manufacturing precision
If aggressive purification steps are used to manufacture bioactive gels from ECM, then purity of the gel is improved, but regulatory burden increases
Solution Approach 1:
The patent changes the manufacturing parameters to use mild, well-characterized solubilization conditions rather than complex purification protocols. This simplifies the process documentation and validation requirements, reducing regulatory burden while maintaining adequate purity for medical use.
Solution Approach 2:
The patent adopts a simplified manufacturing paradigm analogous to disposable products, where a single-step solubilization and gel formation process replaces complex multi-step purification. This reduces the regulatory complexity associated with validating multiple process steps and purification stages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in bioactive gels that effectively assist tissue repair with reduced scar tissue formation and improved restoration of tissue structure and function, while minimizing time and regulatory hurdles.
Implementation Method 1
solubilizing a particularized ECM in a basic (greater than pH 7) environment, which when neutralized with acid provides bioactive gels
Implementation Method 2
solubilizing a particularized ECM in a basic (greater than pH 7) environment, which when neutralized with acid provides bioactive gels
Data Source
Figure 1
Figure 2
AI summary
The present invention is directed to methods of manufacturing bioactive gels from ECM material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ECM material can be created by digesting particularized ECM material in an alkaline environment and neutralizing to provide bioactive gels.